Skip to main navigation Skip to search Skip to main content

Chronic Empagliflozin Treatment Reduces Myocardial Infarct Size in Nondiabetic Mice through STAT-3-Mediated Protection on Microvascular Endothelial Cells and Reduction of Oxidative Stress

  • Panagiota Efstathia Nikolaou
  • , Panagiotis Efentakis
  • , Fairouz Abu Qourah
  • , Saveria Femminò
  • , Manousos Makridakis
  • , Zoi Kanaki
  • , Aimilia Varela
  • , Maria Tsoumani
  • , Constantinos H. Davos
  • , Constantinos A. Dimitriou
  • , Androniki Tasouli
  • , George Dimitriadis
  • , Nikolaos Kostomitsopoulos
  • , Coert J. Zuurbier
  • , Antonia Vlahou
  • , Apostolos Klinakis
  • , Maria F. Brizzi
  • , Efstathios K. Iliodromitis
  • , Ioanna Andreadou*
    • *Corresponding author for this work
  • National and Kapodistrian University of Athens
  • University of Turin
  • Academy of Athens
  • Onassis Cardiac Surgery Center

Research output: Contribution to journal › Article › Academic › peer-review

19 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Chronic Empagliflozin Treatment Reduces Myocardial Infarct Size in Nondiabetic Mice through STAT-3-Mediated Protection on Microvascular Endothelial Cells and Reduction of Oxidative Stress'. Together they form a unique fingerprint.
Sort by

Keyphrases

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science